Dr. Subhashis Chakraborty, general manager, head - global product management at ACG Capsules discusses the European Commission's decision on titanium dioxide in pharmaceuticals.
1. What does the European Commission’s decision mean in practical terms for pharmaceutical manufacturers in Europe?
The Commission’s decision to maintain the use of titanium dioxide (TiO₂) in medicines, based on EMA’s April 2024